May 9, 2018 / 8:17 PM / 3 months ago

BRIEF-Menlo Therapeutics Reports Qtrly Loss Per Share $0.72

May 9 (Reuters) - Menlo Therapeutics Inc:

* MENLO THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

* QTRLY LOSS PER SHARE $0.72

* LOWERING ITS OPERATING EXPENSE GUIDANCE FOR FULL YEAR 2018 TO A RANGE OF APPROXIMATELY $68.0 MILLION TO $78.0 MILLION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below